Investment Summary

DW Healthcare Partners Invests In Noble Pharma

On January 10, 2022, private equity firm DW Healthcare Partners invested in life science company Noble Pharma

Investment Highlights
  • This is DW Healthcare Partners’ 4th transaction in the Life Science sector.
  • This is DW Healthcare Partners’ 34th transaction in the United States.
  • This is DW Healthcare Partners’ 2nd transaction in Wisconsin.

Investment Summary
Date 2022-01-10
Target Noble Pharma
Sector Life Science
Investor(s) DW Healthcare Partners
Deal Type Growth Capital

Target

Noble Pharma

Menomonie, Wisconsin, United States
Noble Pharma is an FDA approved manufacturing facility focused on developing and manufacturing extremely palatable products for the animal health market. Noble has the ability to manufacture soft chews, creams, ointments, suspensions, tablets, powders, and pastes. Noble Pharma is based in Menomonie, Wisconsin.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

DW Healthcare Partners

Park City, Utah, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2002
PE ASSETS 1.5B USD
Size Large
Type Sector Focused
DESCRIPTION

DW Healthcare Partners is a healthcare-focused private equity firm that partners with owners of mid-to late-stage companies. DW looks to invest in private, North American companies, primarily in the medical device, product, services, and specialty distribution sectors of healthcare. DW will invest from $20 to $100 million of equity capital to help facilitate growth or to fund acquisitions. DW looks for high-growth businesses with at least $6 million in EBITDA and prefers to be the majority investor. DW Healthcare Partners was formed in 2002 and is based in Ontario, Canada.

DEAL STATS #
Overall 37 of 39
Sector (Life Science) 4 of 4
Type (Growth Capital) 15 of 17
State (Wisconsin) 2 of 2
Country (United States) 34 of 36
Year (2022) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-10 Vets Plus

Menomonie, Wisconsin, United States

Vets Plus is a full-service developer and manufacturer of nutraceutical solutions for the companion animal and livestock markets. Vets Plus was founded in 1990 and is based in Menomonie, Wisconsin.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-30 Med-Pharmex

Pomona, California, United States

Med-Pharmex is a manufacturer of pharmaceutical products for the animal health market which includes companion and food-producing animals. Med-Pharmex was founded in 1983 and is based in Pomona, California.

Sell -
Mergr

Product

Company

Legal